CY1116682T1 - Διπλασιασμος-μυϊκης μαζας σε θηλαστικα - Google Patents
Διπλασιασμος-μυϊκης μαζας σε θηλαστικαInfo
- Publication number
- CY1116682T1 CY1116682T1 CY20151100796T CY151100796T CY1116682T1 CY 1116682 T1 CY1116682 T1 CY 1116682T1 CY 20151100796 T CY20151100796 T CY 20151100796T CY 151100796 T CY151100796 T CY 151100796T CY 1116682 T1 CY1116682 T1 CY 1116682T1
- Authority
- CY
- Cyprus
- Prior art keywords
- sequence
- protein
- seq
- myostatin
- activity
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 7
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108020004414 DNA Proteins 0.000 abstract 3
- 102000004472 Myostatin Human genes 0.000 abstract 3
- 108010056852 Myostatin Proteins 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 3
- 241000283690 Bos taurus Species 0.000 abstract 2
- 108091026890 Coding region Proteins 0.000 abstract 2
- 206010020718 hyperplasia Diseases 0.000 abstract 2
- 230000003387 muscular Effects 0.000 abstract 2
- 101000886576 Bos taurus Growth/differentiation factor 8 Proteins 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/20—Animal model comprising regulated expression system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/101—Bovine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/891,789 US6103466A (en) | 1997-07-14 | 1997-07-14 | Double-muscling in mammals |
| US776198A | 1998-01-15 | 1998-01-15 | |
| EP08006554.3A EP2045322B1 (en) | 1997-07-14 | 1998-07-14 | Double-muscling in mammals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1116682T1 true CY1116682T1 (el) | 2017-03-15 |
Family
ID=26677351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20151100796T CY1116682T1 (el) | 1997-07-14 | 2015-09-14 | Διπλασιασμος-μυϊκης μαζας σε θηλαστικα |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20030129171A1 (https=) |
| EP (2) | EP2045322B1 (https=) |
| JP (1) | JP4368522B2 (https=) |
| AT (1) | ATE442436T1 (https=) |
| AU (1) | AU756620B2 (https=) |
| CA (1) | CA2296434C (https=) |
| CY (1) | CY1116682T1 (https=) |
| DE (1) | DE69841139D1 (https=) |
| DK (1) | DK2045322T3 (https=) |
| ES (1) | ES2547858T3 (https=) |
| NZ (1) | NZ502523A (https=) |
| PT (1) | PT2045322E (https=) |
| WO (1) | WO1999002667A1 (https=) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5994618A (en) | 1997-02-05 | 1999-11-30 | Johns Hopkins University School Of Medicine | Growth differentiation factor-8 transgenic mice |
| US7393682B1 (en) * | 1993-03-19 | 2008-07-01 | The Johns Hopkins University School Of Medicine | Polynucleotides encoding promyostatin polypeptides |
| US7566768B1 (en) | 1995-10-26 | 2009-07-28 | The Johns Hopkins University School Of Medicine | Promyostatin peptides and methods of using same |
| DK0690873T3 (da) | 1993-03-19 | 2003-09-29 | Univ Johns Hopkins Med | Vækstdifferentieringsfaktor-8 |
| US7332575B2 (en) | 1994-03-18 | 2008-02-19 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| US6008434A (en) | 1994-07-08 | 1999-12-28 | Johns Hopkins University School Of Medicine | Growth differentiation factor-11 transgenic mice |
| GB2333706A (en) * | 1998-02-02 | 1999-08-04 | Merck & Co Inc | Method for increasing muscle mass in animals |
| US6369201B1 (en) * | 1998-02-19 | 2002-04-09 | Metamorphix International, Inc. | Myostatin multimers |
| AU5483599A (en) * | 1998-08-14 | 2000-03-06 | Board Of Regents, The University Of Texas System | Calcineurin-dependent control of skeletal muscle fiber type |
| MXPA01007366A (es) * | 1999-01-21 | 2002-06-04 | Metamorphix Inc | Inhibidores de factores de crecimiento y diferenciacion y usos de los mismos. |
| TR200400621T2 (tr) * | 1999-07-20 | 2004-08-23 | Pharmexa A/S | GDF-8 aktivitesinin aşağı doğru düzenlenmesi için bir yöntem. |
| US6617440B1 (en) * | 1999-07-30 | 2003-09-09 | Pfizer, Inc. | Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| KR20020065509A (ko) * | 2000-09-06 | 2002-08-13 | 티모시 에이. 호지 | 유전자이식 및 표적 돌연변이유발 스크리닝을 위한시스템, 방법 및 장치 |
| US7494817B2 (en) | 2000-09-06 | 2009-02-24 | Transnet Yx, Inc. | Methods for genotype screening using magnetic particles |
| EP1978110B1 (en) | 2000-09-06 | 2010-05-26 | Transnetyx, Inc. | Computer-based method and system for screening genomic DNA |
| US7037501B2 (en) | 2001-01-04 | 2006-05-02 | Regents Of The University Of Minnesota | Myostatin immnoconjugate |
| TW200526779A (en) | 2001-02-08 | 2005-08-16 | Wyeth Corp | Modified and stabilized GDF propeptides and uses thereof |
| US7320789B2 (en) | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
| AR047392A1 (es) * | 2002-10-22 | 2006-01-18 | Wyeth Corp | Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines |
| BR0317538A (pt) | 2002-12-20 | 2005-11-29 | Amgen Inc | Agente ligante, sequência de polinucleotìdeo, vetor de expressão, célula hospedeira, composição farmacêutica, e, métodos de inibir a atividade de miostatina, de aumentar a massa muscular magra e a razão de massa muscular magra para gordura, de tratar uma doença de emaciação muscular e um distúrbio metabólico relacionado com miostatina em um indivìduo, de detectar e medir miostatina em uma amostra, e, de diagnosticar um distúrbio relacionado com miostatina em um indivìduo |
| US7468248B2 (en) | 2002-12-31 | 2008-12-23 | Cargill, Incorporated | Methods and systems for inferring bovine traits |
| RU2322261C2 (ru) | 2003-06-02 | 2008-04-20 | Уайт | Применение ингибиторов миостатика (gdf8) в сочетании с кортикостероидами для лечения нервно-мышечных заболеваний |
| EP1855694B1 (en) | 2005-02-09 | 2020-12-02 | Sarepta Therapeutics, Inc. | Antisense composition for treating muscle atrophy |
| PL2407486T3 (pl) | 2005-08-19 | 2018-05-30 | Wyeth Llc | Przeciwciała antagonistyczne względem GDF-8 i zastosowania w leczeniu ALS i innych zaburzeń związanych z GDF-8 |
| KR100872042B1 (ko) * | 2005-09-14 | 2008-12-05 | 주식회사 바이오리더스 | 마이오스타틴을 발현하는 세포표면 발현벡터 및 상기벡터에 의해 형질전환된 미생물 |
| GB2433320B (en) * | 2005-12-16 | 2009-10-07 | Norwegian University Of Life S | Diagnostic method |
| AU2006345724B2 (en) * | 2006-06-30 | 2013-11-21 | Lakewood-Amedex, Inc. | Compositions and methods for the treatment of muscle wasting |
| KR100857861B1 (ko) * | 2007-10-15 | 2008-09-11 | 주식회사 바이오리더스 | Ｍｙｏ－２ 펩타이드 중합체와 마이오스타틴의 융합단백질표면발현용 벡터 및 상기 벡터로 형질전환된 미생물 |
| US9528124B2 (en) | 2013-08-27 | 2016-12-27 | Recombinetics, Inc. | Efficient non-meiotic allele introgression |
| US10920242B2 (en) | 2011-02-25 | 2021-02-16 | Recombinetics, Inc. | Non-meiotic allele introgression |
| MX363013B (es) * | 2011-02-25 | 2019-03-04 | Recombinetics Inc | Animales genéticamente modificados y métodos para su obtención. |
| US20130085139A1 (en) | 2011-10-04 | 2013-04-04 | Royal Holloway And Bedford New College | Oligomers |
| KR101704893B1 (ko) | 2012-06-15 | 2017-02-08 | 화이자 인코포레이티드 | Gdf-8에 대한 개선된 길항물질 항체 및 그의 용도 |
| AR091482A1 (es) * | 2012-06-21 | 2015-02-04 | Recombinetics Inc | Celulas modificadas geneticamente y metodos par su obtencion |
| RS61778B1 (sr) | 2013-05-06 | 2021-06-30 | Scholar Rock Inc | Kompozicije i postupci za modulaciju faktora rasta |
| EP2960653A1 (en) * | 2014-06-24 | 2015-12-30 | Stichting Kwaliteitsgarantie Vleeskalversector | Diagnostic kit and method for the identification of the manipulation of muscle mass in a domestic animal |
| MA41795A (fr) | 2015-03-18 | 2018-01-23 | Sarepta Therapeutics Inc | Exclusion d'un exon induite par des composés antisens dans la myostatine |
| EP3858993A1 (en) * | 2015-10-09 | 2021-08-04 | Sarepta Therapeutics, Inc. | Compositions and methods for treating duchenne muscular dystrophy and related disorders |
| CN106472430A (zh) * | 2016-10-21 | 2017-03-08 | 延边朝鲜族自治州农业科学院（延边特产研究所） | 一种寒冷地区烟蚜茧蜂冬季保种方法 |
| CN110269867B (zh) * | 2018-03-14 | 2022-06-21 | 必康生技（香港）有限公司 | 用于生物流体净化的组合物 |
| CN110157818B (zh) * | 2019-07-08 | 2023-04-25 | 云南东恒经贸集团猪育种有限公司 | 一种与猪眼肌高产性状相关的分子标记及其应用 |
| GB2636643B (en) * | 2020-12-03 | 2026-03-11 | Lart Bio Co Ltd | Transgenic animal having modified myostatin gene |
| CN120192396A (zh) * | 2023-12-21 | 2025-06-24 | 江苏省农业科学院 | 一种肌肉生长抑制素mstn蛋白突变体及其制备方法和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5264558A (en) | 1987-06-19 | 1993-11-23 | The Regents Of The University Of California | Single-chain monellin analog as a low calorie protein sweetner |
| MX9203458A (es) | 1987-12-23 | 1992-09-01 | Upjohn Co | Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano. |
| US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| GB9021679D0 (en) | 1990-10-05 | 1990-11-21 | Gorman Scott David | Antibody preparation |
| US5162209A (en) * | 1991-01-18 | 1992-11-10 | Beth Israel Hospital Association | Synthesis of full-length, double-stranded dna from a single-stranded linear dna template |
| US5962316A (en) * | 1992-10-16 | 1999-10-05 | Cold Spring Harbor Laboratory | Cell-cycle regulatory proteins, and uses related thereto |
| DK0690873T3 (da) * | 1993-03-19 | 2003-09-29 | Univ Johns Hopkins Med | Vækstdifferentieringsfaktor-8 |
| NZ279855A (en) * | 1994-02-04 | 1998-05-27 | Bio Merieux | Msrv1 and msrv2 pathogenic and/or infectious agents associated with ms, nucleic acids encoding them and diagnostic and therapeutic applications |
| AU6274298A (en) * | 1997-02-05 | 1998-08-25 | Johns Hopkins University School Of Medicine, The | Growth differentiation factor-8 |
-
1998
- 1998-07-14 AU AU84571/98A patent/AU756620B2/en not_active Expired
- 1998-07-14 JP JP2000502165A patent/JP4368522B2/ja not_active Expired - Lifetime
- 1998-07-14 EP EP08006554.3A patent/EP2045322B1/en not_active Expired - Lifetime
- 1998-07-14 WO PCT/IB1998/001197 patent/WO1999002667A1/en not_active Ceased
- 1998-07-14 EP EP98935228A patent/EP1002068B1/en not_active Expired - Lifetime
- 1998-07-14 NZ NZ502523A patent/NZ502523A/xx not_active IP Right Cessation
- 1998-07-14 DE DE69841139T patent/DE69841139D1/de not_active Expired - Lifetime
- 1998-07-14 PT PT80065543T patent/PT2045322E/pt unknown
- 1998-07-14 DK DK08006554.3T patent/DK2045322T3/en active
- 1998-07-14 ES ES08006554.3T patent/ES2547858T3/es not_active Expired - Lifetime
- 1998-07-14 AT AT98935228T patent/ATE442436T1/de not_active IP Right Cessation
- 1998-07-14 CA CA2296434A patent/CA2296434C/en not_active Expired - Lifetime
-
2002
- 2002-09-20 US US10/251,115 patent/US20030129171A1/en not_active Abandoned
-
2015
- 2015-09-14 CY CY20151100796T patent/CY1116682T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69841139D1 (de) | 2009-10-22 |
| CA2296434C (en) | 2013-10-15 |
| AU756620B2 (en) | 2003-01-16 |
| US20030129171A1 (en) | 2003-07-10 |
| WO1999002667A1 (en) | 1999-01-21 |
| EP1002068A1 (en) | 2000-05-24 |
| ES2547858T3 (es) | 2015-10-09 |
| EP2045322B1 (en) | 2015-07-01 |
| NZ502523A (en) | 2003-02-28 |
| JP2001509378A (ja) | 2001-07-24 |
| EP2045322A1 (en) | 2009-04-08 |
| PT2045322E (pt) | 2015-10-16 |
| CA2296434A1 (en) | 1999-01-21 |
| AU8457198A (en) | 1999-02-08 |
| ATE442436T1 (de) | 2009-09-15 |
| JP4368522B2 (ja) | 2009-11-18 |
| EP1002068B1 (en) | 2009-09-09 |
| DK2045322T3 (en) | 2015-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1116682T1 (el) | Διπλασιασμος-μυϊκης μαζας σε θηλαστικα | |
| TR200103297T2 (tr) | Nöral ve renal gelişmenin uyarılması için Ret ligandı (RetL) | |
| ATE405589T1 (de) | Für den snorf25-rezeptor kodierende dna | |
| ATE189607T1 (de) | Dna codierend für einen menschlichen neuropeptid y/peptid yy/pankreaspolypeptid-rezeptor (y4) und seine verwendung | |
| ES2083344T1 (es) | Dna que codifica un receptor 5-ht1f humano y utilizacion del mismo. | |
| EP1132402A4 (en) | PEPTIDE FRAGMENTS WITH CELL DEATH PREVENTIVE ACTIVITY | |
| ATE512217T1 (de) | 5-substituerte hydantoin racemase, dafür kodierende dna, und verfahren zur herstellung optisch aktiver aminosäure | |
| DE69816987D1 (de) | Verfahren und zusammenstellungen zur identifiezierung von genetisch resistenten schweinen gegen f18 e. coli assozierte krankheiten | |
| DK1129191T3 (da) | Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme | |
| EP1065269A4 (en) | GENE CODING FOR HM1.24 AND PROMOTOR THEREOF | |
| DE60234843D1 (de) | Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten | |
| DE69734890D1 (de) | Rdgb-proteine | |
| DE69943149D1 (en) | Serinprotease bssp2 | |
| SE9701344D0 (sv) | Transgenic, non-human animal with protein deficiency, cells derived therefrom, use of said animal and cells, and method of producing said transgenic animal | |
| DK0754754T3 (da) | Gen for FK506 bindende protein | |
| AU5779690A (en) | Mutation of the rhinovirus system | |
| WO2000068433A3 (en) | Autism gene | |
| DE60021707D1 (de) | Beta-primeverosidase gen | |
| JP2003189884A5 (https=) |